Rapid Influenza Diagnostics Market Share

North American Market Forecasts

The North America rapid influenza diagnostics market is estimated to account for the highest revenue share of 33% by the end of 2037. The United States dominated the North American fast influenza diagnostic market in 2021, and it is predicted that it will continue to grow quickly throughout the foreseeable future. This can be attributed to the existence of significant market participants, a rise in the number of influenza cases, respiratory infections, etc. The CDC estimates that between October 1, 2021, and April 16, 2022, there were between 4,700,000 and 7,900,000 flu cases reported in the United States. Additionally, this flu season caused between 2,800 and 8,200 fatalities in the United States. These data demonstrate the growing need for influenza testing in the region that effectively uses quick diagnostic assays for the illness.

APAC Market Statistics

The rapid influenza diagnostics market in the Asia Pacific region is estimated to grow substantially by the end of the forecast period. The growth of this market can be ascribed to the back of growing healthcare expenditure in the region as a result of growing urbanization. Besides, increasing awareness about rapid influenza diagnostics among the people living in this world is expected to raise the market expansion of the market in the region during the forecast period.